NightCAP: Reducing Hypnotic Drug Use and Improving Night-time Care

Summary

Dementia is a devastating condition characterised by progressive loss of cognition leading to loss of independence and eventually death. One major unmet need, which remains a critical challenge for care provision, is the management of night-time care and sleep-related symptoms in people with dementia living in care homes. The causes and impacts of sleep disturbances in people with dementia in care homes are complex and multi-faceted, indicating the need of a whole-systems approach to the issue. It will require a tailored, person-centred approach which accounts for the environmental, personal and clinical factors contributing to the symptoms.

The aim of this study is to evaluate the NightCAP intervention to improve treatment of sleep disturbance in people with dementia in care homes, with the goal of reducing sleep disturbance behaviour and reducing the use of hypnotic drugs. This will provide robust evidence to support guidance on night time care and improving hypnotic drug prescribing, both of which are major unmet needs in the care of people with dementia.

Conditions

• Dementia

Interventions

BEHAVIORAL

Hypnotic Medication Review

A training programme focused providing guidance on the review and withdrawal process of hypnotic drugs.

BEHAVIORAL

Structured Sleep Hygiene

Training module on the principle of good sleep hygiene

BEHAVIORAL

Night Time Care Activities Programme

Training and support package to assist in the development of a personalised night time care plan and support the implementation and dissemination of information within the care home environment

Sponsors & Collaborators

• King's College London

  collaborator OTHER

• University of East Anglia

  collaborator OTHER

• Aston University

  collaborator OTHER

• University of Exeter

  lead OTHER

Principal Investigators

• Anne Corbett · University of Exeter

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

PARALLEL

Eligibility

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2021-11-01

Primary Completion

2023-04-30

Completion

2023-04-30

Countries

• United Kingdom

Study Locations